We report a liquid-chromatographic method for assay of total and free propranolol and its metabolite, propranolol glycol, in plasma. An ultrafiltration device is used to separate the free drugs from the protein-bound drugs. The total and free drugs are isolated from plasma or ultrafiltrate by liquid-solid extraction on a Waters C18 SEP-PAK and the drugs are quantified on a C18 z-Bondpak radial-compression column. The mobile phase consists of equal parts of methanol and a solution of potassium 50 mmol/L phosphate and 2.5 mmol/L 1-pentanesulfonic acid, pH 5.0. Detection was by fluorescence, with excitation at 296 nm and emission at 338 nm. Time required for sample preparation for total-propranolol assay is 40 mm per eight samples. Sample preparation for free-propranolol assay requires an additional 1 h per eight samples. Chromatography requires 15 mm per sample. The extraction recovery is approximately 75% and the assay curve is linear from 5 to 400 g/L. The run-to-run CV is 4% for total propranolol, 15% for free propranolol.
tion as an alternative to equilibrium dialysis, and many applications have been reported in which this technique is used to assay free drugs (20) (21) (22) , hormones (23) (24) (25) , and ions (26, 27) .
Ultrafiltration,
in conjunction with our simplified sample-preparation procedure, provides an improved method of analysis for total and free propranolol.
Materials and Methods

Materials
DL-Propranolol hydrochloride and sodium 1-pentanesulfonic acid were from Sigma Chemical Co., St. Louis, MO.
Propranolol glycol, 4-hydroxypropranolol hydrochloride, and 4-methylpropranolol were kindly supplied by Ayerst Laboratory, New York,NY. "HPLC grade" methanol (ultraviolet cutoff, 205 nm) was obtained from Fisher Scientific, Fair Lawn, NJ. All other reagents were reagent grade. "Centrifree" ultrafiltration devices were from Amicon Corp.,
Danvers, MA.
Drug stock and working solutions.
Stock 100 mgfL solutions of propranolol hydrochloride, propranolol glycol, 4-hydroxypropranolol, and 4-methylpropranolol (internal standard) were in methanol. The working standard solutions of the drugs were prepared by diluting the stock solutions with de-ionized water to give concentrations of 10 mg/L. These standard solutions were stable for at least six months when stored at 4#{176}C.
"High-Performance" Liquid Chromatography:
Instrumentation and Conditions
This system consisted of a Model 6000A pump, Model U6K injector, a Radial PAK -Bondpak C18cartridge, 5-tim particle size, and a Z-module radial compression system, all from Waters Associates, Milford, MA. The detector was a SF-330 spectrofluorometer (Varian, Palo Alto, CA) with a quartz flow cell, with excitation set at 296 nm and emission set at 338 nm. The mobile phase was equal parts of methanol and a solution of 50 mmol/L KH2PO4 and 2.5 minol/L sodium 1-pentanesulfonic acid, pH 5.0. The flow rate was 2 mL/min.
Procedures
Procedure for total propranolol. Immediately before adding a sample, wash the SEP-PAK C18 cartridges successively with 5 mL of de-ionized water, 2 mL of methanol, and 2 mL of de-ionized water, to activate them. Adjust the pH of the plasma sample to 7.0 and add internal standard to give a concentration of 100 /Lg/L. Aspirate 1 mL of the sample through the 5EP-PAI, followed by 5 mL of de-ionized water. Elute the drugs from the SEP-PAX with 2 mL of methanol, collect the eluate, and evaporate it in a water bath set at 50#{176}C, under a constant air flow. Dissolve the residue in 100 tL of methanol and inject the solution onto the chromatographic column. rotor for 10 mm at 25 #{176}C and 2000 x g. The ultrauIltrate containing the free drug collects in the sample cup while the protein and bound drugs remain in the sample reservoir. Treat the filtrate in the same manner as the plasma for total propranolol.
Measurements.
Peak-height ratios for the sample are compared with similar ratios from a plasma standard containing the drugs at 100 .tgfL.
Recovery study. Analytical recovery of propranolol and propranolol glycol from plasma were determined by comparing the peak heights of the extracted drugs with the peak heights of the corresponding drug obtained by direct injection of the equivalent unextracted standard solution.
Drug-interference studies. Several drugs and drug metabolites were tested for potential interference of the assay by injecting extracts of plasma containing the drugs into the chromatograph. Figure 1 shows chromatograms of the drug standards, a blank plasma, and plasma to which propranolol and propranolol glycol were added. The extraction procedure and chromatographic conditions result in a linear response (Figure 2 ) for concentrations from 5 to 400 pg/L for both propranolol and propranolol glycol. The peak-height ratio increased linearly with increasing concentrations of drugs up to 1000 ng/mL. However, a change in attenuation was required on the recorder for concentrations exceeding 400 g/L.
Results and DIscussIon
The precision of the method was determined at two drug concentrations.
A pooled plasma was split and supplemented to either 20 g/L or 150 ugfL. Aliquots were frozen,and one aliquot was assayed per day during a month. Table 1 , taken through this procedure, did not interfere with the quantification of propranolol or its metabolite.
It was necessary to evaluate the possible loss of drug by binding to components of the Centrifree (membrane, rubber gasket, etc). The working standard was diluted with water to give 40 g each of propranolol and propranolol glycol per liter. A 1-mL aliquot was adjusted to pH 7.0 and filtered successivelythrough five different Centrifree ultrafiltration To determine if propranolol glycol or 4-hydroxypropranolol could effectively compete for the propranolol binding sites in plasma, we supplemented a plasma pool with propranolol to 200 tgfL and then split it into aliquots. Propranolol glycol or 4-hydroxypropranolol even at high concentrations had no effect on the concentrations of free propranolol in the samples. or 4-hydroxy propranolol even at high concentrations had no effect on the concentrations of free propranolol in the samples.
Our detector could not simultaneously measure propranolol and its metabolite, 4-hydroxypropranolol.
The conditions for maximum sensitivity for propranolol, propranolol glycol and 4-methylpropranolol (excitation 295 nm, emssion 338 nm) were not suitable for the detection of 4-hydroxypropranolol (333 and 401 mm, respectively).
In conclusion: this method offers an improved technique for the assay of free propranolol that avoids equilibrium dialysis. In addition, we report a rapid liquid-solid extraction procedure that is more efficient and precise than the traditional liquid-liquid extraction protocols.
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